ATAI Life Sciences N.V. (ATAI) Financials
ATAI Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 308.2 million | 39.7 million |
2023-06-30 | 253.6 million | 38.0 million |
2023-03-31 | 280.7 million | 276.9 million |
2022-12-31 | 305.4 million | 300.4 million |
ATAI Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -18.4 million | 8.3 million |
2023-06-30 | -22.7 million | 8.8 million |
2023-03-31 | -21.6 million | 8.7 million |
2022-12-31 | -30.7 million | 12.1 million |
ATAI Net Income
No data available :(
ATAI Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 209.0 million | - | 1.3 million |
2023-06-30 | 227.5 million | 14.9 million | 1.4 million |
2023-03-31 | 249.9 million | 14.8 million | 1.5 million |
2022-12-31 | 273.1 million | 14.7 million | - |
ATAI Shares Outstanding
ATAI Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 2000 | 13.3 million | 13.6 million | - |
2023-06-30 | 128000 | 15.5 million | 16.6 million | - |
2023-03-31 | 443000 | 19.3 million | 14.0 million | - |
2022-12-31 | 223000 | 21.9 million | 15.7 million | - |
ATAI Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 87000 | 74000 |
2023-06-30 | 172000 | 195000 |
2023-03-31 | 37000 | 167000 |
2022-12-31 | 38000 | 53000 |
ATAI
Price: $2.05
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.43 USD
P/E Ratio: -4.16
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 1.5 million
Ebitda: 9.8 millionMarket Capitalization: 403.4 million
Average Dividend Frequency: 1